These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 18706401)
21. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228 [TBL] [Abstract][Full Text] [Related]
22. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study. Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244 [TBL] [Abstract][Full Text] [Related]
23. Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism. Ozsu S; Karaman K; Mentese A; Ozsu A; Karahan SC; Durmus I; Oztuna F; Kosucu P; Bulbul Y; Ozlu T Thromb Res; 2010 Dec; 126(6):486-92. PubMed ID: 20920821 [TBL] [Abstract][Full Text] [Related]
24. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Khan SQ; Narayan H; Ng KH; Dhillon OS; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Clin Sci (Lond); 2009 Jun; 117(1):31-9. PubMed ID: 19170658 [TBL] [Abstract][Full Text] [Related]
25. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications? Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108 [TBL] [Abstract][Full Text] [Related]
26. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079 [TBL] [Abstract][Full Text] [Related]
27. An increase of BNP levels in massive pulmonary embolism and the reduction in response to the acute treatment. Altintop L; Yardan T; Cander B; Findik S; Yilmaz O Resuscitation; 2005 May; 65(2):225-9. PubMed ID: 15866405 [TBL] [Abstract][Full Text] [Related]
28. N-terminal brain natriuretic peptide as a diagnostic test in cirrhotic patients with pulmonary arterial hypertension. Bernal V; Pascual I; Esquivias P; García-Gil A; Mateo JM; Lacambra I; Serrano MT; Simón MA Transplant Proc; 2009 Apr; 41(3):987-8. PubMed ID: 19376405 [TBL] [Abstract][Full Text] [Related]
29. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Yap LB; Ashrafian H; Mukerjee D; Coghlan JG; Timms PM Clin Biochem; 2004 Oct; 37(10):847-56. PubMed ID: 15369714 [TBL] [Abstract][Full Text] [Related]
33. Carbonic anhydrase IX in the prediction of right ventricular dysfunction in patients with hemodynamically stable acute pulmonary embolism. Abul Y; Ozsu S; Mentese A; Durmus I; Bektas H; Pehlivanlar M; Turan OE; Sumer A; Orem A; Ozlu T Clin Appl Thromb Hemost; 2014 Nov; 20(8):838-43. PubMed ID: 23613041 [TBL] [Abstract][Full Text] [Related]
34. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Puls M; Dellas C; Lankeit M; Olschewski M; Binder L; Geibel A; Reiner C; Schäfer K; Hasenfuss G; Konstantinides S Eur Heart J; 2007 Jan; 28(2):224-9. PubMed ID: 17127709 [TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptides for the evaluation of exercise intolerance. Mueller C; Maeder MT; Christ A; Reichlin T; Staub D; Noveanu M; Breidthardt T; Potocki M; Brutsche MH Am J Med; 2009 Mar; 122(3):265-72. PubMed ID: 19272488 [TBL] [Abstract][Full Text] [Related]
36. Is it possible to use standard electrocardiography for risk assessment of patients with pulmonary embolism? Kostrubiec M; Hrynkiewicz A; Pedowska-Włoszek J; Pacho S; Ciurzyński M; Jankowski K; Koczaj-Bremer M; Wojciechowski A; Pruszczyk P Kardiol Pol; 2009 Jul; 67(7):744-50. PubMed ID: 19649996 [TBL] [Abstract][Full Text] [Related]
37. Utility of brain natriuretic peptide to predict right ventricular dysfunction and clinical outcome in patients with acute pulmonary embolism. Krüger S; Merx MW; Graf J Circulation; 2003 Sep; 108(13):e94; author reply e94-5. PubMed ID: 14517156 [No Abstract] [Full Text] [Related]
38. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation. Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612 [TBL] [Abstract][Full Text] [Related]
39. Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction. Sandhu S; Har BJ; Aggarwal SG; Kavanagh KM; Ramadan D; Exner DV; Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S86-9. PubMed ID: 19250120 [TBL] [Abstract][Full Text] [Related]
40. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea. van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]